You are here

Molecular Imaging


In a recent editorial published in the November issue of The New England Journal of Medicine (NEJM), Werner Hacke, MD, PhD, DSc, discussed a new era of imaging selections for patients who are looking to benefit from a thrombectomy performed long after the onset of a stroke.

According to a new study published by the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine (AJRCCM), obstructive sleep apnea (OSA) may increase elderly individuals' risk of developing Alzheimer's disease.  

Using PET with the radiotracer 18F-florbetapir, researchers in Sweden have found that the topology of amyloid clusters can help tip off clinicians to the presence and progression of Alzheimer’s disease in patients who don’t yet present symptoms.

Radiology and orthopedics researchers at Stanford have shown the prowess of nuclear imaging for identifying the specific source(s) of pain and reduced mobility in patients with chronic sciatica, a common low-back condition notorious for evading such pinpointing.

The effects of space travel on the human anatomy are extensive to say the least, taking into account the harsh impact zero gravity and the rapid ascension into space have on the bodies of astronauts. Yet, the amount of information detailing the effects spaceflight has on the configuration of astronauts' brains is limited, claimed in a recent study published by The New England Journal of Medicine and funded by the National Aeronautics and Space Administration (NASA). 


Recent Headlines

Gamma Medica, Hospital Services Limited to expand into European breast imaging market

Gamma Medica, a molecular breast imaging (MBI) technology company, reached an agreement with Hospital Services Limited (HSL), a medical device company that distributes, installs and services radiology capital equipment and medical devices.

MRI detects signs of autism in high-risk infants

Researchers, who used MRI on infants who have older siblings with autism, were able to correctly predict about 80 percent of those infants who would later develop autism.

Mallinckrodt sells nuclear imaging business to IBA Molecular for $690 million

St. Louis-based Mallinckrodt closed the $690 million sale of its nuclear imaging division to IBA Molecular, a national supplier of radiopharmaceutical products.

Researchers pinpoint genetic risk factors for breast cancer

Clinicians may be able to more accurately predict a woman’s risk of breast cancer, as researchers from the University of Adelaide and the Hospital Research Foundation have identified a gene that contributes to tumor development in women with dense breasts.

Engineering company to test thrombectomy device in clinical trial

Amnis Therapeutics, a biomedical engineering company in Israel, has received approval from the Karolinska Institute, a medical university in Stockholm, Sweden, to use its neuro-thrombectomy device on patients for the first time in a clinical trial.

Parental obesity linked to slow development in children

A new study from the National Institutes of Health (NIH) found a link between slow development in young children and obesity rates of parents.

fMRI used to analyze psychotropic drug use in autistic patients

Neuroscientists from Rutgers University have found that trying to control bodily movement and treating children with autism using psychotropic drugs may worsen their neuromotor problems.

Intraoperative imaging technology cuts need for repetitive lumpectomy

Lightpoint Medical, developers of medical imaging technologies, has announced results for its clinical trial in regards to intraoperative imaging technology for breast cancer surgery.

Could herpes meds slow down the onset of Alzheimer’s?

Existing research that shows a medication designed to treat herpes could also be beneficial to individuals suffering with Alzheimer’s. The treatment is being tested in a new clinical study.

PET scans show patients with PTSD have imbalance in brain's signalling systems

Researchers set out to study patients with post-traumatic stress disorder (PTSD) using PET scans. They found that a greater imbalance between two neurochemical systems in the brain—serotonin and substance P—meant individuals were more likely to experience PTSD symptoms.